TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-12
DOI
10.1038/s41598-019-48024-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Severe steatosis induces portal hypertension by systemic arterial hyporeactivity and hepatic vasoconstrictor hyperreactivity in rats
- (2018) Denise Van der Graaff et al. LABORATORY INVESTIGATION
- The ACE2/Angiotensin-(1–7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1–7)
- (2018) Robson Augusto Souza Santos et al. PHYSIOLOGICAL REVIEWS
- Portal Hypertension Complications Are Frequently the First Presentation of NAFLD in Patients Undergoing Liver Transplantation Evaluation
- (2016) Sajan Jiv Singh Nagpal et al. DIGESTIVE DISEASES AND SCIENCES
- Current and upcoming pharmacotherapy for non-alcoholic fatty liver disease
- (2016) Yaron Rotman et al. GUT
- Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
- (2016) Serena Pelusi et al. PLoS One
- Inhibition of Janus kinase-2 signalling pathway ameliorates portal hypertensive syndrome in partial portal hypertensive and liver cirrhosis rats
- (2015) Dong Wang et al. DIGESTIVE AND LIVER DISEASE
- Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis
- (2015) Sabine Klein et al. GUT
- The Role of RAAS Inhibition by Aliskiren on Paracetamol-Induced Hepatotoxicity Model in Rats
- (2015) Saliha Sena Karcioglu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Expanding consensus in portal hypertension
- (2015) Roberto de Franchis JOURNAL OF HEPATOLOGY
- Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
- (2015) Sabine Klein et al. PLoS One
- Angiotensin-II type 1 receptor-mediated Janus kinase 2 activation induces liver fibrosis
- (2014) Michaela Granzow et al. HEPATOLOGY
- Renin-angiotensin system and fibrosis in non-alcoholic fatty liver disease
- (2014) George B Goh et al. LIVER INTERNATIONAL
- Activation of the Mas Receptor by Angiotensin-(1–7) in the Renin–Angiotensin System Mediates Mesenteric Vasodilatation in Cirrhosis
- (2013) Josephine A. Grace et al. GASTROENTEROLOGY
- Direct renin inhibitor, aliskiren, attenuates the progression of non-alcoholic steatohepatitis in the rat model
- (2013) Yosuke Aihara et al. HEPATOLOGY RESEARCH
- Aliskiren Attenuates Steatohepatitis and Increases Turnover of Hepatic Fat in Mice Fed with a Methionine and Choline Deficient Diet
- (2013) Kuei-Chuan Lee et al. PLoS One
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
- (2013) Ingmar Mederacke et al. Nature Communications
- Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease
- (2012) Flavia D. Mendes et al. Clinical Gastroenterology and Hepatology
- Aliskiren attenuates chronic carbon tetrachloride-induced liver injury in mice
- (2012) Kuei-Chuan Lee et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Aliskiren reduces portal pressure and intrahepatic resistance in biliary cirrhotic rats
- (2012) Yun-Cheng Hsieh et al. Journal of the Chinese Medical Association
- Increased intrahepatic resistance in severe steatosis: endothelial dysfunction, vasoconstrictor overproduction and altered microvascular architecture
- (2012) Sven Francque et al. LABORATORY INVESTIGATION
- Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
- (2012) Marcos Pasarín et al. PLoS One
- Aliskiren reduces portal pressure in portal hypertensive rats
- (2011) Ching-Chih Chang et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- A position statement on NAFLD/NASH based on the EASL 2009 special conference
- (2010) Vlad Ratziu et al. JOURNAL OF HEPATOLOGY
- Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
- (2010) Jonel Trebicka et al. JOURNAL OF HEPATOLOGY
- Angiotensin-(1–7), an alternative metabolite of the renin–angiotensin system, is up-regulated in human liver disease and has antifibrotic activity in the bile-duct-ligated rat
- (2009) John S. Lubel et al. CLINICAL SCIENCE
- Irbesartan Plus Low-Dose Propranolol Versus Low-Dose Propranolol Alone in Cirrhosis: A Placebo-Controlled, Double-Blind Study
- (2008) Michael Schepke et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Mechanisms of Hepatic Fibrogenesis
- (2008) Scott L. Friedman GASTROENTEROLOGY
- Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats
- (2008) Yongzhong Wei et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now